As research on Alzheimer's disease becomes a growing societal priority worldwide, the National Institute on Aging and the Alzheimer's Association have launched the International Alzheimer's Disease Research Portfolio (IARDP). By organizing thousands of studies on AD into one central database, IADRP will help sponsors identify funded research to avoid duplication, coordinate funding efforts, and spot gaps in support. Researchers may fine it useful for the same reasons. With the participation of nine funding agencies and four more that joined recently, the organizers aim to create a comprehensive overview of global efforts to fund Alzheimer's research.
"We want to be as strategic as possible in our funding...and determine the best way spend our research dollars," said Heather Synder of the Alzheimer's Association. The collaborative efforts took lessons from a comparable partnership established more than a decade ago for the cancer community, called the International Cancer Research Partnership, she said.
Launched in the spring of 2012, the IADRP database has steadiliy gained contributors. It now contains funding data from 2008-2011 for six federal and three private agencies: the National Institutes of Health; Administration on Aging; Agency for Healthcare Research and Quality; Centers for Disease Control and Prevention; U.S. Army Medical Research and Material Commaned; U.S. Department of Veteran Affairs; Alzheimer's Association; Alzheimer's Drug Discovery Foundation (ADDF); and Alzheimer's Research UK.